Elastin peptide fingerprints and analysis methods for MMP12 related to COPD
AssigneeAstraZeneca AB
InventorsPer Broberg, Thomas Fehniger, György Marko-Varga, Stephan Uebel
Life of this patent
Estimating the term…
Abstract
Methods for producing and using protein/peptide fingerprints, allowing identification and investigation of disease-associated proteins/peptides that can be linked to specific drug targets, or to specific drug target combinations. The methods are particularly useful for studies relating to Chronic Obstructive Pulmonary Disease (COPD), especially for the enzyme MMP12.
Claims5
A set of purified peptides comprising peptide products resulting from the degradation of elastin by the enzyme matrix metalloproteinase 12 (MMP 12), wherein the set of peptides comprises at least twenty of the peptides identified in Table 2.
A set of purified peptides comprising purified peptide products resulting from the degradation of elastin by the enzyme matrix metalloproteinase 12 (MMP12), wherein the set of peptides comprises all the peptides identified in Table 1.
Dependencies are inferred from the claim text.